| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |